Clinical trial
Controlled Trial of Valacyclovir in Infectious Mononucleosis
NCT00274404 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00274404 |
|---|---|
| Title | Controlled Trial of Valacyclovir in Infectious Mononucleosis |
| Official title | Randomized Study Assessing the Antiviral Activity and Safety of Valacyclovir in Primary Infectious Mononucleosis |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | Minnesota Medical Foundation Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Infectious Mononucleosis |
| Intervention type | Drug |
| Interventions | valacyclovir |
| Enrollment | 20 |
| Start date | Feb 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Jan 10, 2006 |
| Last update posted | Oct 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: